Tag: disease modifying therapies
The challenge of accessing MS treatment in Yemen
The Yemeni Association for the Care of Multiple Sclerosis Patients fights for treatment for people with MS
Successful advocacy results in cladribine access for Iran
Adding MS treatments to the WHO Essential Medicines List leads to real-world benefit
People with MS in Albania given new hope with widening access to MS treatment
Fondacioni Pema e Jetës (Tree of Life Foundation) successfully advocated for reimbursed access to MS treatments
الاتحاد الدولي للتصلّب العصبي المُتعدّد يُسلّط الضوء على الاستخدام الأخلاقي للعلاجات المُعدِّلة للمرض خارج غرضها المخصص من أجل التصلّب العصبي المُتعدِّد
New publication from MSIF on ethical use of off-label DMTs receives global endorsement
كيف يمكن أن تؤدي العلاجات المختلفة المعدّلة للمرض إلى تأخير ترقي المرض
A new study examined different disease modifying therapies and their ability to slow the onset of secondary progressive MS.
دراسةٌ توضح ظهور تحسّن في نتائج توظيف الأشخاص ذوي التصلّب المتعدد
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown a link between more effective disease-modifying therapies and an increased level of employment, work attendance and productivity at work.